Finasteride works for the majority of men with pattern hair loss. At the standard 1 mg daily dose, it reduces the hormone responsible for hair miniaturization by about 64% in the scalp and 71% in the bloodstream. In clinical studies, roughly 86% of men showed improvement after five years of use, and over 98% at least maintained their existing hair without further loss.
How Finasteride Slows Hair Loss
Male pattern hair loss is driven by dihydrotestosterone (DHT), a potent form of testosterone that gradually shrinks hair follicles until they stop producing visible hair. Finasteride blocks the enzyme that converts testosterone into DHT. At the 1 mg dose used for hair loss, scalp DHT drops by about 64% and serum DHT by about 71%. That’s enough to take pressure off vulnerable follicles and, in many cases, allow them to recover some thickness.
Notably, there’s very little practical difference between the 1 mg dose (prescribed for hair loss) and the 5 mg dose (prescribed for prostate conditions). Studies comparing the two found no significant difference in hair regrowth, which is why the lower dose remains the standard.
What Results Look Like Over Time
Finasteride isn’t fast. Most men notice reduced shedding by around month three, but visible thickening typically doesn’t appear until six to nine months in. Results peak at 12 to 18 months of continuous use. This long runway is one reason many men abandon the drug prematurely, mistaking a slow start for failure.
In a Korean study following 126 men over five years, 85.7% showed measurable improvement. When including men who simply held steady without losing more hair, that figure rose to 98.4%. Longer-term data is more variable. A 10-year Italian study found that 38.6% of men still showed improvement at that point, a lower number that likely reflects both the natural progression of hair loss over a decade and the difficulty of maintaining perfect adherence to a daily pill for that long. The takeaway: finasteride reliably works for years, but it can’t freeze hair loss in place forever for everyone.
Where It Works Best on the Scalp
Finasteride has historically been considered most effective at the crown (vertex), which is where the largest clinical trials measured results. But research specifically examining the frontal hairline found significant increases in hair count there too, with improvements that held or continued through a second year of treatment. So while the crown tends to respond more dramatically, the front of the scalp also benefits. Men with loss concentrated at the temples or frontal hairline shouldn’t rule finasteride out based on the outdated idea that it only works at the crown.
Combining Finasteride With Minoxidil
Using finasteride alongside topical minoxidil produces better results than either treatment alone. A meta-analysis of randomized trials found that the combination improved hair density, hair diameter, and overall photographic assessments compared to minoxidil by itself. Men using both treatments were about 3.3 times more likely to achieve “marked improvement” in standardized photos than those using minoxidil alone. The logic is straightforward: finasteride reduces the hormonal signal that shrinks follicles, while minoxidil stimulates blood flow and extends the growth phase. They target different parts of the problem.
What Happens If You Stop
Finasteride only works while you take it. Once you stop, DHT levels rebound within days. The follicles that were protected begin miniaturizing again, and hair counts typically drift back toward where they would have been without treatment over the following 6 to 12 months. This doesn’t mean you lose hair faster than if you’d never started. It means the protection disappears and normal pattern loss resumes.
Side Effects in Context
Sexual side effects are the primary concern most men have, and the data paints a nuanced picture. Across major clinical trials, sexual side effects occurred in roughly 2% to 4% of men taking finasteride. Erectile difficulties were the most commonly reported, followed by changes in ejaculation and reduced sex drive. However, two large studies found that the rates of these side effects were comparable to those seen in men taking a placebo, suggesting that expectation and awareness play a role.
A long-term study tracked these effects over five years and found that the incidence of each sexual side effect dropped to 0.3% or less by year five, rates indistinguishable from placebo. A separate systematic review did find a statistically significant increase in erectile dysfunction (about 2.2 times the risk of placebo), but the absolute numbers remained small, and men experiencing side effects were no more likely to discontinue treatment than those on placebo. For most men, the side effects that do occur are mild enough that they continue treatment.
The concept of “post-finasteride syndrome,” where sexual or neurological symptoms persist after stopping the drug, has received attention online but remains poorly understood and controversial in clinical literature. The vast majority of men who experience side effects find they resolve after discontinuation.